Terms: = Colorectal cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Prognosis
3 results:
1. Deficiency of sdhc promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X
J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.
Dong G; He X; Chen Y; Cao H; Wang J; Liu X; Wang S; Wan S; Xing J
Mol Cancer; 2015 Sep; 14():171. PubMed ID: 26377099
[TBL] [Abstract] [Full Text] [Related]
